Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
H1N1 (Swine Flu) and You
Life Expectancy With HIV Increases Dramatically
HIV Associated With Marked Declines in Lung Function
Is Marijuana as Effective as OTC and Prescription Drugs?
HPV Vaccine Is Active in MSM
MACS Turns 25: The Influential HIV Study Continues
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 8, 2007

New Worries With AIDS Vaccine

Previous immunity to adenovirus 5 (Ad5), a common cold virus, may explain why volunteers receiving Merck’s preventive HIV vaccine may have been more likely to become infected with HIV than those receiving placebo injections, suggest researchers associated with the international STEP study. The new information was reported yesterday at a special gathering of HIV Vaccine Trials Network (HVTN) researchers and community advocates in Seattle.

Ad5 was used in the vaccine being developed by Merck and studied by HVTN. The shell of the virus was used as a vector to deliver pieces of HIV’s genetic material to immune system cells.

According to researchers at the meeting in Seattle, 49 male participants who received the vaccine became infected with HIV, compared with 33 males who received the placebo. There was only one infection among female participants, so they were not included in the post-study analysis. The difference in infections among the men was particularly striking when they looked at participants whose immune systems were strongly reactive to the Ad5 vector: 21 of those vaccine recipients became infected with HIV compared with just 9 who received a placebo.

The researchers cautioned that the numbers are so small and the data so new, that it is way too early to tell whether this trend toward greater HIV susceptibility in the vaccine recipients is real, or merely coincidence. They promised to continue analyzing the data with speed and intensity in hopes of answering this question as soon as possible.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 3 (of 3 total)    

Ala Moana, bronx, NYC, 2007-11-13 22:29:39
Perhaps a prphyllactic vaccine is necessary...one that can be taken, and therefore tested, by people already infected with HIV. It's preferable to infecting healthy people.

Tim Horn, AIDSmeds.com, New York, 2007-11-13 09:04:09
Cesar- Check out of AIDSmeds.com Forums (forums.poz.com) and connect with other HIV-positive people and experts who can can possibly help you with this.

cesar figueroa, brooklyn, n.y., 2007-11-12 19:22:15
I've been pos. since 89 my meds are working for wild but then stop. My T-Cell go up and down v. lo. is in the thousands. I've never been undeteable. What should I do? I've have give up on meds. Write back.

comments 1 - 3 (of 3 total)    


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]